Skip to main content
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: Open J Immunol. 2018 Jun 29;8(2):36–80. doi: 10.4236/oji.2018.82004

Table 1.

Treatments robust to immune strength level, tumor size and resistance.

Treatment Combinations Treatment Description Time to Elimination
M1 macrophages + Fresolimumab 8 weekly injections of M1 macrophages and 4 biweekly injections of F. 102 days
Th1 helper cells + Fresolimumab 17 weekly injections of Th1 helper cells and 9 biweekly injections of F. 160 days
M1 macrophages + Fresolimumab + Sunitinib 1 cycle of S concurrent with 3 biweekly injections of M1 and 3 biweekly injections of F. 56 days
Th1 helper cells + Fresolimumab + Sunitinib 2 cycles of S concurrent with 6 biweekly injections of Th1 and 6 biweekly injections of F (Th1 at a reduced dose of vT1 = 5 × 106 cells/L · day). 108 days